Received Oct 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Dizziness; Low blood pressure; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of dizziness in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on an unknown date). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced dizziness (Verbatim: Dizziness) and low blood pressure (Verbatim: Low blood pressure). Rechallenge with Shingrix was positive. The outcome of the dizziness and low blood pressure were not reported. It was unknown if the reporter considered the dizziness and low blood pressure to be related to Shingrix. It was unknown if the company considered the dizziness and low blood pressure to be related to Shingrix. Linked case(s) involving the same patient: US2025119609 Additional Information: GSK Receipt Date: 17-SEP-2025 Patient had a similar reaction to a Boniva shot as well. Had the same reaction to both doses of Shingrix. This was 1 of the 2 linked cases, reported by the same reporter.; Sender's Comments: US-GSK-US2025119609:Same patient/different dose 1